Editas Medicine Inc (EDIT)
3.83
-0.12
(-3.04%)
USD |
NASDAQ |
Sep 16, 15:01
Editas Medicine Price: 3.83 for Sept. 16, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 13, 2024 | 3.78 | 3.97 | 3.78 | 3.95 | 1.289M |
| Sep 12, 2024 | 3.79 | 3.84 | 3.635 | 3.75 | 1.124M |
| Sep 11, 2024 | 3.73 | 3.79 | 3.625 | 3.78 | 1.196M |
| Sep 10, 2024 | 3.54 | 3.789 | 3.445 | 3.77 | 1.842M |
| Sep 09, 2024 | 3.64 | 3.64 | 3.48 | 3.51 | 1.942M |
| Sep 06, 2024 | 3.49 | 3.615 | 3.40 | 3.59 | 1.970M |
| Sep 05, 2024 | 3.50 | 3.55 | 3.42 | 3.49 | 1.660M |
| Sep 04, 2024 | 3.47 | 3.556 | 3.40 | 3.50 | 1.456M |
| Sep 03, 2024 | 3.73 | 3.77 | 3.465 | 3.49 | 1.695M |
| Aug 30, 2024 | 3.75 | 3.775 | 3.65 | 3.74 | 1.137M |
| Aug 29, 2024 | 3.72 | 3.786 | 3.675 | 3.71 | 1.547M |
| Aug 28, 2024 | 3.78 | 3.81 | 3.62 | 3.68 | 1.644M |
| Aug 27, 2024 | 3.88 | 3.93 | 3.72 | 3.82 | 1.334M |
| Aug 26, 2024 | 3.90 | 3.99 | 3.85 | 3.92 | 1.038M |
| Aug 23, 2024 | 3.82 | 4.00 | 3.77 | 3.87 | 1.700M |
| Aug 22, 2024 | 4.08 | 4.08 | 3.78 | 3.79 | 1.492M |
| Aug 21, 2024 | 4.01 | 4.15 | 3.955 | 4.08 | 1.711M |
| Aug 20, 2024 | 4.13 | 4.13 | 3.905 | 3.96 | 1.128M |
| Aug 19, 2024 | 4.01 | 4.19 | 3.995 | 4.10 | 1.910M |
| Aug 16, 2024 | 3.98 | 4.075 | 3.92 | 4.00 | 1.012M |
| Aug 15, 2024 | 3.81 | 4.10 | 3.81 | 4.00 | 1.895M |
| Aug 14, 2024 | 4.03 | 4.03 | 3.71 | 3.74 | 1.718M |
| Aug 13, 2024 | 3.96 | 4.05 | 3.93 | 3.99 | 1.042M |
| Aug 12, 2024 | 3.99 | 3.99 | 3.82 | 3.92 | 1.425M |
| Aug 09, 2024 | 4.21 | 4.22 | 3.92 | 3.97 | 1.796M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.49
Minimum
Sep 03 2024
90.58
Maximum
Jan 08 2021
22.45
Average
17.49
Median
Mar 01 2022
Price Benchmarks
| Intellia Therapeutics Inc | 21.64 |
| Biogen Inc | 198.85 |
| Regeneron Pharmaceuticals Inc | 1157.12 |
| Vertex Pharmaceuticals Inc | 488.52 |
| Moderna Inc | 69.62 |
Price Related Metrics
| PS Ratio | 4.680 |
| Price to Book Value | 1.362 |
| Earnings Yield | -61.62% |
| Market Cap | 315.88M |